Cadila Healthcare informs about press release

23 Jul 2020 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated on July 23, 2020 titled ‘Zydus receives approval from USFDA to initiate clinical trials of Desidustat in cancer patients receiving chemotherapy’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

929.05 6.60 (0.72%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×